Cargando…
TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism
TRIpartite motif (TRIM) proteins are part of the largest subfamilies of E3 ligases that mediate the transfer of ubiquitin to substrate target proteins. In this review, we focus on TRIM37 in the normal cell and in pathological conditions, with an emphasis on the MULIBREY (MUscle-LIver-BRain-EYe) gene...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337287/ https://www.ncbi.nlm.nih.gov/pubmed/30586926 http://dx.doi.org/10.3390/ijms20010067 |
_version_ | 1783388218920534016 |
---|---|
author | Brigant, Benjamin Metzinger-Le Meuth, Valérie Rochette, Jacques Metzinger, Laurent |
author_facet | Brigant, Benjamin Metzinger-Le Meuth, Valérie Rochette, Jacques Metzinger, Laurent |
author_sort | Brigant, Benjamin |
collection | PubMed |
description | TRIpartite motif (TRIM) proteins are part of the largest subfamilies of E3 ligases that mediate the transfer of ubiquitin to substrate target proteins. In this review, we focus on TRIM37 in the normal cell and in pathological conditions, with an emphasis on the MULIBREY (MUscle-LIver-BRain-EYe) genetic disorder caused by TRIM37 mutations. TRIM37 is characterized by the presence of a RING domain, B-box motifs, and a coiled-coil region, and its C-terminal part includes the MATH domain specific to TRIM37. MULIBREY nanism is a rare autosomal recessive caused by TRIM37 mutations and characterized by severe pre- and postnatal growth failure. Constrictive pericarditis is the most serious anomaly of the disease and is present in about 20% of patients. The patients have a deregulation of glucose and lipid metabolism, including type 2 diabetes, fatty liver, and hypertension. Puzzlingly, MULIBREY patients, deficient for TRIM37, are plagued with numerous tumors. Among non-MULIBREY patients affected by cancer, a wide variety of cancers are associated with an overexpression of TRIM37. This suggests that normal cells need an optimal equilibrium in TRIM37 expression. Finding a way to keep that balance could lead to potential innovative drugs for MULIBREY nanism, including heart condition and carcinogenesis treatment. |
format | Online Article Text |
id | pubmed-6337287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63372872019-01-22 TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism Brigant, Benjamin Metzinger-Le Meuth, Valérie Rochette, Jacques Metzinger, Laurent Int J Mol Sci Review TRIpartite motif (TRIM) proteins are part of the largest subfamilies of E3 ligases that mediate the transfer of ubiquitin to substrate target proteins. In this review, we focus on TRIM37 in the normal cell and in pathological conditions, with an emphasis on the MULIBREY (MUscle-LIver-BRain-EYe) genetic disorder caused by TRIM37 mutations. TRIM37 is characterized by the presence of a RING domain, B-box motifs, and a coiled-coil region, and its C-terminal part includes the MATH domain specific to TRIM37. MULIBREY nanism is a rare autosomal recessive caused by TRIM37 mutations and characterized by severe pre- and postnatal growth failure. Constrictive pericarditis is the most serious anomaly of the disease and is present in about 20% of patients. The patients have a deregulation of glucose and lipid metabolism, including type 2 diabetes, fatty liver, and hypertension. Puzzlingly, MULIBREY patients, deficient for TRIM37, are plagued with numerous tumors. Among non-MULIBREY patients affected by cancer, a wide variety of cancers are associated with an overexpression of TRIM37. This suggests that normal cells need an optimal equilibrium in TRIM37 expression. Finding a way to keep that balance could lead to potential innovative drugs for MULIBREY nanism, including heart condition and carcinogenesis treatment. MDPI 2018-12-24 /pmc/articles/PMC6337287/ /pubmed/30586926 http://dx.doi.org/10.3390/ijms20010067 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Brigant, Benjamin Metzinger-Le Meuth, Valérie Rochette, Jacques Metzinger, Laurent TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism |
title | TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism |
title_full | TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism |
title_fullStr | TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism |
title_full_unstemmed | TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism |
title_short | TRIMming down to TRIM37: Relevance to Inflammation, Cardiovascular Disorders, and Cancer in MULIBREY Nanism |
title_sort | trimming down to trim37: relevance to inflammation, cardiovascular disorders, and cancer in mulibrey nanism |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337287/ https://www.ncbi.nlm.nih.gov/pubmed/30586926 http://dx.doi.org/10.3390/ijms20010067 |
work_keys_str_mv | AT brigantbenjamin trimmingdowntotrim37relevancetoinflammationcardiovasculardisordersandcancerinmulibreynanism AT metzingerlemeuthvalerie trimmingdowntotrim37relevancetoinflammationcardiovasculardisordersandcancerinmulibreynanism AT rochettejacques trimmingdowntotrim37relevancetoinflammationcardiovasculardisordersandcancerinmulibreynanism AT metzingerlaurent trimmingdowntotrim37relevancetoinflammationcardiovasculardisordersandcancerinmulibreynanism |